Literature DB >> 977790

Influence of renal dysfunction on warfarin plasma protein binding.

K Bachmann, R Shapiro, J Mackiewicz.   

Abstract

The in vitro plasma protein binding of warfarin was evaluated by ultrafiltration in plasma from seven normal subjects and seven patients with varying degrees of renal dysfunction. The unbound, or free, warfarin fraction was twice as high in the plasma samples withdrawn from patients with renal impairment than in the samples obtained from normal volunteers. Furthermore, there was a positive correlation between the extent of renal dysfunction and the magnitude of the free warfarin fraction when either creatinine clearance, plasma creatinine, or BUN was used to estimate renal function.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 977790

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  10 in total

Review 1.  Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II).

Authors:  R Zini; P Riant; J Barré; J P Tillement
Journal:  Clin Pharmacokinet       Date:  1990-09       Impact factor: 6.447

Review 2.  Protein binding of coumarin anticoagulants in disease states.

Authors:  K Bachmann; R Shapiro
Journal:  Clin Pharmacokinet       Date:  1977 Mar-Apr       Impact factor: 6.447

3.  Alteration of drug-protein binding in renal disease.

Authors:  M M Reidenberg; D E Drayer
Journal:  Clin Pharmacokinet       Date:  1984-01       Impact factor: 6.447

Review 4.  The pharmacological role of the kidney.

Authors:  D C Brater
Journal:  Drugs       Date:  1980-01       Impact factor: 9.546

5.  Plasma protein binding of azapropazone in patients with kidney and liver disease.

Authors:  E Jähnchen; K J Blanck; K H Breuing; H J Gilfrich; T Meinertz; D Trenk
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

Review 6.  The effect of chronic renal failure on drug metabolism and transport.

Authors:  Albert W Dreisbach; Juan J L Lertora
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-08       Impact factor: 4.481

Review 7.  Plasma protein binding of digitoxin and some other drugs in renal disease.

Authors:  J J Lohman; F W Merkus
Journal:  Pharm Weekbl Sci       Date:  1987-04-24

8.  Decreased binding of drugs and dyes to plasma proteins from rats with acute renal failure: effects of ureter ligation and intramuscular injection of glycerol.

Authors:  C J Bowmer; W E Lindup
Journal:  Br J Pharmacol       Date:  1979-06       Impact factor: 8.739

9.  Efficacy and safety of vitamin K-antagonists (VKA) for atrial fibrillation in non-dialysis dependent chronic kidney disease.

Authors:  Judith Kooiman; Nienke van Rein; Bas Spaans; Koen A J van Beers; Jonna R Bank; Wilke R van de Peppel; Antonio Iglesias del Sol; Suzanne C Cannegieter; Ton J Rabelink; Gregory Y H Lip; Frederikus A Klok; Menno V Huisman
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

10.  Risk of overanticoagulation during acute kidney injury in patients treated with vitamin K antagonists.

Authors:  Luisa Süfling; Daniel Greinert; Matthias Girndt
Journal:  Nephrol Dial Transplant       Date:  2022-03-25       Impact factor: 5.992

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.